Pages that link to "Q36661066"
Jump to navigation
Jump to search
The following pages link to Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints (Q36661066):
Displaying 50 items.
- Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals (Q26995405) (← links)
- Ushering in the study and treatment of preclinical Alzheimer disease (Q27014791) (← links)
- The BEHAVE-AD assessment system: a perspective, a commentary on new findings, and a historical review (Q27022753) (← links)
- Neuroimaging biomarkers of neurodegenerative diseases and dementia (Q27691820) (← links)
- Triad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex (Q28077056) (← links)
- The link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies (Q30830414) (← links)
- Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline (Q30996727) (← links)
- Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review (Q31096423) (← links)
- Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies (Q33590723) (← links)
- Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging (Q33761290) (← links)
- Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible (Q33773031) (← links)
- Memory concerns, memory performance and risk of dementia in patients with mild cognitive impairment (Q33895227) (← links)
- Brain imaging in the study of Alzheimer's disease (Q34102331) (← links)
- Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's (Q34258737) (← links)
- Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention (Q34303501) (← links)
- Age-related differences in white matter integrity and cognitive function are related to APOE status (Q34380707) (← links)
- Prospective memory on a novel clinical task in older adults with mild cognitive impairment and subjective cognitive decline (Q34479022) (← links)
- Subjective word-finding difficulty reduces engagement in social leisure activities in Alzheimer's disease (Q34549485) (← links)
- Subjective cognitive concerns, episodic memory, and the APOE ε4 allele (Q34621679) (← links)
- The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function (Q34674417) (← links)
- Neuroimaging Measures as Endophenotypes in Alzheimer′s Disease (Q34924165) (← links)
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease (Q35049917) (← links)
- Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology (Q35067938) (← links)
- Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia (Q35555134) (← links)
- A FDG-PET Study of Metabolic Networks in Apolipoprotein E ε4 Allele Carriers (Q35688137) (← links)
- Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly (Q35850701) (← links)
- Early dysfunction of functional connectivity in healthy elderly with subjective memory complaints (Q35853635) (← links)
- Subjective cognitive complaints of older adults at the population level: an item response theory analysis (Q35916563) (← links)
- Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults (Q35940991) (← links)
- Predicting Alzheimer's disease: neuropsychological tests, self-reports, and informant reports of cognitive difficulties (Q36034307) (← links)
- Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies (Q36197614) (← links)
- Subjective memory complaints, cognitive performance, and psychological factors in healthy older adults (Q36198927) (← links)
- Differential focal and nonfocal prospective memory accuracy in a demographically diverse group of nondemented community-dwelling older adults (Q36219183) (← links)
- Gray and White Matter Degenerations in Subjective Memory Impairment: Comparisons with Normal Controls and Mild Cognitive Impairment (Q36241746) (← links)
- APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern (Q36259716) (← links)
- Subjective cognitive complaints and amyloid burden in cognitively normal older individuals (Q36322792) (← links)
- Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study (Q36361729) (← links)
- White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease. (Q36437623) (← links)
- Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population (Q36764582) (← links)
- Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations (Q36795245) (← links)
- Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease (Q37141206) (← links)
- Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings. (Q37283742) (← links)
- The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory. (Q37300271) (← links)
- Relationships between biomarkers in aging and dementia (Q37393992) (← links)
- Outcome over seven years of healthy adults with and without subjective cognitive impairment (Q37414902) (← links)
- Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly (Q37524486) (← links)
- A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease (Q37590389) (← links)
- Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection (Q37639158) (← links)
- Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review (Q37689697) (← links)
- Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging (Q37698055) (← links)